mTOR/MLST8/RPTOR Complex Recombinant

Catalog #
102073
$525 *
Size: 10 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Complex of mTOR (mammalian target of rapamycin), encompassing amino acids 1362-2549, full length MLST8 (target of rapamycin complex subunit LST8) and full length RPTOR (regulatory-associated protein of mTOR). The mTOR construct contains an N-terminal FLAG-tag, while MLST8 and RPTOR include an N-terminal Strep-tag. The proteins were expressed, and affinity purified as a complex.

Synonyms
mTOR, mechanistic target of rapamycin, FRAP, FKBP-Rapamycin Associated Protein, Mammalian Target Of Rapamycin, raptor, regulatory associated protein of mTOR, Mip1, MLST8, Mammalian Lethal With SEC13 Protein 8, GBL, Gable, POP3, LST8
Product Info
Storage and Usage
Citations
Species
Human
Construct
mTOR (FLAG-1362-2549(end)) / MLST8 (Strep-2-326(end)) / RPTOR (Strep-2-1335(end))
Host Species/Expression System
Sf9
Purity

≥80%

Format

Aqueous buffer solution.

Formulation

80 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.8 mM EDTA, 2 mM desthiobiotin, and 20% Glycerol

MW
mTOR: 137 kDa; MLST8: 37 kDa; RPTOR: 150 kDa
Amino Acids
mTOR: 1362-2549(end); MLST8: 2-326(end); RPTOR: 2-1335(end)
Genbank #
mTOR: NM_004958; MLST8: NM_022372; RPTOR: NM_020761
UniProt #
mTOR: NM_004958; MLST8: NM_022372; Raptor: NM_020761
Tag(s)
N-Terminal FLAG-Tag, N-Terminal Strep-Tag
Background

mTOR (mammalian target of rapamycin) is a serine/threonine kinase protein of the PIK3 (phosphatidylinositol 3- kinase)-related family. It can form two different complexes, which differ in the accessory protein present and have different biological functions. mTORC1 (mTOR complex 1) includes the protein RPTOR (regulatory-associated protein of mTOR), while mTORC2 is composed of RICTOR (RPTOR independent companion of mTOR complex 2). MLST8 (target of rapamycin complex subunit LST8) is common to both complexes and seems to stabilize the active site of mTOR and participate in its activation. mTORC1 is activated in response to growth factors and responds to activation of the PI3K-AKT (protein kinase B) pathway. It is involved in cell growth via phosphorylation of proteins like 4E-BP1 (eIF-4E-binding protein). Dysfunction of mTORC1 can result in cancer, and strategies targeting mTORC1 may result in major advances in cancer therapy.